A B7-H4 targeting antibody-drug conjugate shows anti-tumor activity in PARPi and platinum resistant cancers with B7-H4 expression

被引:0
|
作者
Gitto, Sarah B.
Whicker, Margaret
Davies, Gareth
Kumar, Sushil
Kinneer, Krista
Lewis, Arthur
Mamidi, Srinivas
Medvedev, Sergey
Anderton, Judith
Tang, Jessica
Ferman, Benjamin
Coats, Steve
Wilkinson, Robert W.
Brown, Eric J.
Powell, Daniel J.
Simpkins, Fiona
机构
关键词
D O I
10.1158/1538-7445.AM2023-1133
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1133
引用
收藏
页数:3
相关论文
共 50 条
  • [1] A B7-H4-Targeting Antibody-Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression
    Gitto, Sarah B.
    Whicker, Margaret
    Davies, Gareth
    Kumar, Sushil
    Kinneer, Krista
    Xu, Haineng
    Lewis, Arthur
    Mamidi, Srinivas
    Medvedev, Sergey
    Kim, Hyoung
    Anderton, Judith
    Tang, E. Jessica
    Ferman, Benjamin
    Coats, Steven
    Wilkinson, Robert W.
    Brown, Eric
    Powell, Daniel J.
    Simpkins, Fiona
    CLINICAL CANCER RESEARCH, 2024, 30 (08) : 1567 - 1581
  • [2] SGN-B7H4V, A NOVEL, INVESTIGATIONAL VEDOTIN ANTIBODY-DRUG CONJUGATE DIRECTED TO THE T CELL CHECKPOINT LIGAND B7-H4, SHOWS PROMISING
    Gray, Elizabeth
    Epp, Angela
    Ulrich, Michelle
    Sahetya, Disha
    Hensley, Kelly
    Hahn, Julie
    Allred, Sean
    Haass, Jane
    Snead, Katie
    Lucas, Sasha
    Gosink, John
    Boyce, Rogely
    Trueblood, Esther
    Treuting, Piper
    Frantz, Chris
    Smith, Alyson
    Schrum, Jason
    Nazarenko, Natalya
    Gardai, Shyra
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A895 - A895
  • [3] Potential targeting of B7-H4 for the treatment of cancer
    Podojil, Joseph R.
    Miller, Stephen D.
    IMMUNOLOGICAL REVIEWS, 2017, 276 (01) : 40 - 51
  • [4] B7-H4's Role "Beyond the Tumor"
    Yu, Ning
    Li, Xiaomei
    Zheng, Songguo
    Li, Xiangpei
    INFLAMMATION, 2013, 36 (04) : 941 - 947
  • [5] B7-H4’s Role “Beyond the Tumor”
    Ning Yu
    Xiaomei Li
    Songguo Zheng
    Xiangpei Li
    Inflammation, 2013, 36 : 941 - 947
  • [6] Antibody targeting of B7-H4 enhances the immune response in urothelial carcinoma
    Podojil, Joseph R.
    Glaser, Alexander P.
    Baker, Dylan
    Courtois, Elise T.
    Fantini, Damiano
    Yu, Yanni
    Eaton, Valerie
    Siyajothi, Santhosh
    Chiang, Mingyi
    Das, Arighno
    McLaughlin, Kimberly A.
    Robson, Paul
    Miller, Stephen D.
    Meeks, Joshua J.
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [7] Expression of B7-H3 and B7-H4 in experimental autoimmue encephalomyelitis
    Bando, Yoshio
    Zhu, Bing
    Albin, Monica
    Chitnis, Tanuja
    Sayegh, Mohamed
    Khoury, Samia J.
    NEUROLOGY, 2007, 68 (12) : A338 - A338
  • [8] Expression of B7-H3 and B7-H4 in experimental autoimmune encephalomyelitis
    Bando, Yoshio
    Zhu, Bing
    Chitinis, Tanuja
    Yoshida, Shigetaka
    Khoury, Samia
    NEUROSCIENCE RESEARCH, 2008, 61 : S109 - S109
  • [9] XMT-1660: A Phase 1b trial of a B7-H4 targeting antibody drug conjugate (ADC) in endometrial, ovarian, and breast cancers
    Hamilton, Erika
    Spira, Alexander
    Adams, Sylvia
    Abuhadra, Nour
    Giordano, Antonio
    Parajuli, Ritesh
    Han, Hyo
    Weise, Amy
    Marchesani, Aubri
    Josephs, Kate
    Chaudhry, Arvind
    Kalinsky, Kevin
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S158 - S158
  • [10] XMT-1660: A PHASE 1B TRIAL OF A B7-H4 TARGETING ANTIBODY DRUG CONJUGATE (ADC) IN ENDOMETRIAL, OVARIAN, AND BREAST CANCERS
    Hamilton, Erika
    Chaudhry, Arvind
    Spira, Alex
    Adams, Sylvia
    Abuhadra, Nour
    Giordano, Antonio
    Parajuli, Ritesh
    Han, Hyo
    Weise, Amy
    Marchesani, Aubri
    Josephs, Kate
    Im, Ellie
    Shin, Chu Ri
    Kalinsky, Kevin
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A228 - A229